학술논문

A Randomized Trial of Nafamostat for Covid-19.
Document Type
Article
Source
NEJM Evidence; Nov2023, Vol. 2 Issue 11, p8-8, 1p
Subject
THERAPEUTIC use of protease inhibitors
VASOCONSTRICTORS
HOSPITALS
COVID-19
CONFIDENCE intervals
PROTEASE inhibitors
ANTIVIRAL agents
TREATMENT effectiveness
RANDOMIZED controlled trials
STATISTICAL sampling
ODDS ratio
HYPERKALEMIA
PATIENT care
Language
ISSN
27665526
Abstract
Copyright of NEJM Evidence is the property of MMS Publications and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Online Access